Skip to main content
. Author manuscript; available in PMC: 2023 Oct 1.
Published in final edited form as: J Addict Dis. 2022 Mar 14;40(4):542–551. doi: 10.1080/10550887.2022.2042152

Table 3.

Odds of Opioid/Benzodiazepine Simultaneous Use

MODEL 1: PTSD
Variable B (SE) p value OR (95% CI)
Simultaneous use in past year
 Age −0.04 (0.02) .120 0.97 (0.92, 1.01)
 Female 0.14 (0.40) .716 1.16 (0.53, 2.51)
 Positive PTSD Screen 1.15 (0.41) .005* 3.16 (1.42, 7.08)
 Perceived Great Risk in Simultaneous use −1.35 (0.42) .003* 0.29 (0.13, 0.65)
Simultaneous use prior to past year
 Age −0.01 (0.01) .356 0.99 (0.96, 1.01)
 Female 0.25 (0.28) .364 1.29 (0.75, 2.23)
 Positive PTSD Screen −0.05 (0.30) .880 0.96 (0.53, 1.73)
 Perceived Great Risk in Simultaneous use −0.27 (0.33) .406 0.76 (0.40, 1.48)
MODEL 2: Depression
Simultaneous use in Past Year 1
 Age −0.06 (0.02) .013* 0.95 (0.91, 0.99)
 Female 0.17 (0.39) .664 1.19 (0.55, 2.55)
 Depressive symptoms 0.21 (0.09) .014* 1.24 (1.04, 1.47)
 Perceived Great Risk in Simultaneous use −1.02 (0.41) .013* 0.36 (0.16, 0.80)
Simultaneous use Prior to Past Year 1
 Age −0.01 (0.01) .384 0.99 (0.96, 1.02)
 Female 0.25 (0.28) .362 1.29 (0.75, 2.22)
 Depressive symptoms −0.01 (0.07) .772 0.99 (0.86, 1.14)
 Perceived Great Risk in Simultaneous use −0.29 (0.33) .386 0.75 (0.40, 1.43)
MODEL 3: Anxiety
Simultaneous use in Past Year 1
 Age −0.05 (0.02) .020* 0.95 (0.91, 0.99)
 Female 0.14 (0.39) .728 1.15 (0.53, 2.48)
 Anxiety symptoms 0.27 (0.09) .004* 1.31 (1.09, 1.57)
 Perceived Great Risk in Simultaneous use −1.08 (0.41 .009* 0.34 (.15, 0.77)
Simultaneous use Prior to Past Year 1
 Age −0.01 (0.01) .369 0.99 (0.96, 1.01)
 Female 0.24 (0.28) .387 1.27 (0.74, 2.20)
 Anxiety symptoms 0.02 (0.07) .769 1.02 (0.89, 1.17)
 Perceived Great Risk in Simultaneous use −0.28 (0.33) .397 0.76 (0.40, 1.44)
1.

Reference = Never engaged in simultaneous use. Mental health conditions were entered into separate regressions due to high levels of overlap between the conditions.